Immune Thrombocytopenia (ITP)

DBCOND0035132Anatomical Structures and FluidsCardiovascular Diseases

Immune Thrombocytopenia (ITP) is the indication for 12 drugs in DrugBank. It is covered by 12 curated, structured indications.

Also known as
Purpura, Thrombocytopenic, Idiopathic · Immune Thrombocytopenic Purpura ( ITP ) · Immune Thrombocytopenic Purpura · Idiopathic Thrombocytopenic Purpura · Purpura, Thrombocytopaenic, Idiopathic
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0025253ICD-10D69.3SNOMED CT128091003MedDRA10021243UMLSC0242584

What you can answer from here — as of October 03, 2026

12Indicated drugsWith each drug's targets and mechanism
Listed above
12Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
433Clinical trialsPhase, status and sponsor resolved per trial
Sign in
5Contraindicated drugsDrugs whose labels contraindicate them in this condition
Sign in
1Boxed warningLabel boxed warnings that name this condition
Sign in
27Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Immune Thrombocytopenia (ITP) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In